Literature DB >> 22252826

PXR variants and artemisinin use in Vietnamese subjects: frequency distribution and impact on the interindividual variability of CYP3A induction by artemisinin.

Rita Piedade1, Elke Schaeffeler, Stefan Winter, Sara Asimus, Matthias Schwab, Michael Ashton, Oliver Burk, José P Gil.   

Abstract

Artemisinins induce drug metabolism through the activation of the pregnane X receptor (PXR) in vitro. Here, we report the resequencing and genotyping of PXR variants in 75 Vietnamese individuals previously characterized for CYP3A enzyme activity after artemisinin exposure. We identified a total of 31 PXR variants, including 5 novel single nucleotide polymorphisms (SNPs), and we identified significantly different allele frequencies relative to other ethnic groups. A trend of significance was observed between the level of CYP3A4 induction by artemisinin and two PXR variants, the 8118C→T (Y328Y) and 10719A→G variants.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22252826      PMCID: PMC3318324          DOI: 10.1128/AAC.06009-11

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  34 in total

1.  Mitochondrial DNA polymorphism in the Vietnamese population.

Authors:  R Ivanova; A Astrinidis; V Lepage; S Djoulah; E Wijnen; A N Vu-Trieu; J Hors; D Charron
Journal:  Eur J Immunogenet       Date:  1999-12

2.  Genotyping of the PXR A11156C polymorphism with locked nucleic acid containing fluorogenic probes.

Authors:  R A M Op den Buijsch; J E de Vries; W J G Loots; O Landt; P A H M Wijnen; M P van Dieijen-Visser; O Bekers
Journal:  Pharmacogenomics J       Date:  2005       Impact factor: 3.550

3.  The human pregnane X receptor: genomic structure and identification and functional characterization of natural allelic variants.

Authors:  J Zhang; P Kuehl; E D Green; J W Touchman; P B Watkins; A Daly; S D Hall; P Maurel; M Relling; C Brimer; K Yasuda; S A Wrighton; M Hancock; R B Kim; S Strom; K Thummel; C G Russell; J R Hudson; E G Schuetz; M S Boguski
Journal:  Pharmacogenetics       Date:  2001-10

4.  Screening for polymorphisms in the PXR gene in a Dutch population.

Authors:  Tessa M Bosch; Maarten Deenen; Roelof Pruntel; Paul H M Smits; Jan H M Schellens; Jos H Beijnen; Irma Meijerman
Journal:  Eur J Clin Pharmacol       Date:  2006-03-28       Impact factor: 2.953

5.  Antimalarial artemisinin drugs induce cytochrome P450 and MDR1 expression by activation of xenosensors pregnane X receptor and constitutive androstane receptor.

Authors:  Oliver Burk; Katja A Arnold; Andreas K Nussler; Elke Schaeffeler; Ekaterina Efimova; Bonnie A Avery; Mitchell A Avery; Martin F Fromm; Michel Eichelbaum
Journal:  Mol Pharmacol       Date:  2005-03-10       Impact factor: 4.436

Review 6.  Progress in the development of piperaquine combinations for the treatment of malaria.

Authors:  Umberto D'alessandro
Journal:  Curr Opin Infect Dis       Date:  2009-12       Impact factor: 4.915

7.  Tacrolimus population pharmacokinetic-pharmacogenetic analysis and Bayesian estimation in renal transplant recipients.

Authors:  Khaled Benkali; Aurelie Prémaud; Nicolas Picard; Jean-Philippe Rérolle; Olivier Toupance; Guillaume Hoizey; Alain Turcant; Florence Villemain; Yannick Le Meur; Pierre Marquet; Annick Rousseau
Journal:  Clin Pharmacokinet       Date:  2009       Impact factor: 6.447

Review 8.  Nuclear receptors CAR and PXR: Molecular, functional, and biomedical aspects.

Authors:  Alessandra di Masi; Elisabetta De Marinis; Paolo Ascenzi; Maria Marino
Journal:  Mol Aspects Med       Date:  2009-05-07

9.  The pregnane X receptor locus is associated with susceptibility to inflammatory bowel disease.

Authors:  Megan M Dring; Carol A Goulding; Valerie I Trimble; Denise Keegan; Anthony W Ryan; Karen M Brophy; Claire M Smyth; P W Napoleon Keeling; Diarmuid O'Donoghue; Maria O'Sullivan; Colm O'Morain; Nasir Mahmud; Ann-Charlotte Wikström; Dermot Kelleher; Ross McManus
Journal:  Gastroenterology       Date:  2006-02       Impact factor: 22.682

Review 10.  Understanding the pharmacokinetics of Coartem.

Authors:  Abdoulaye Djimdé; Gilbert Lefèvre
Journal:  Malar J       Date:  2009-10-12       Impact factor: 2.979

View more
  3 in total

1.  Influences of an NR1I2 polymorphism on heterogeneous antiplatelet reactivity responses to clopidogrel and clinical outcomes in acute ischemic stroke patients.

Authors:  Yi-Bei Chen; Zi-Yi Zhou; Guo-Min Li; Can-Xing Xiao; Wei-Bang Yu; Shi-Long Zhong; Ye-Feng Cai; Jing Jin; Min Huang
Journal:  Acta Pharmacol Sin       Date:  2018-11-28       Impact factor: 6.150

2.  PXR and CAR single nucleotide polymorphisms influence plasma efavirenz levels in South African HIV/AIDS patients.

Authors:  Marelize Swart; Heather Whitehorn; Yuan Ren; Peter Smith; Rajkumar S Ramesar; Collet Dandara
Journal:  BMC Med Genet       Date:  2012-11-22       Impact factor: 2.103

3.  Pharmacogenomics of Cytochrome P450 3A4: Recent Progress Toward the "Missing Heritability" Problem.

Authors:  Kathrin Klein; Ulrich M Zanger
Journal:  Front Genet       Date:  2013-02-25       Impact factor: 4.599

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.